Telix Pharmaceuticals Ltd has released a press release.
Telix 1H 2024 Results Presentation
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Telix Pharmaceuticals
- Telix 1H 2024 Appendix 4D and Interim Report
- Telix Completes A$650 Million of Convertible Bonds
- Convertible Bond Cleansing Notice
- Telix Successfully Prices A$650M Convertible Bonds
- Telix Announces A$600 Million Convertible Bonds Offering
Later from Telix Pharmaceuticals
- Telix 1H 2024 Results Release
- Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent
- Telix to Acquire RLS for US Manufacturing and Distribution
- Telix Q3 2024 Revenue and Business Update
- Telix Files Form 20-F Registration Statement for Nasdaq ADS
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals